Search - tctmd.com

Displaying 321 - 340 of 701

Sort: Relevancy | Date

News Daily News

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Yael L. Maxwell

September 18, 2017

Manuscript

Cerebral Embolic Protection: Point–Counter Point

September 08, 2017

News Conference News ESC 2017

EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib

Todd Neale

September 05, 2017

News Industry News

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

September 05, 2017

Manuscript

Cerebral Embolic Protection: Not Enough Evidence to Support Routine Clinical Use

August 14, 2017

Presentation CHIP Seattle 2017

How a CHIP Operator Manages Saphenous Vein Graft (SVG) Disease

Presenter: John M. Lasala

August 11, 2017

Podcast

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

August 10, 2017

Presentation SOLACI 2017

Role of Embolic Protection during TAVR

Presenter: Samir Kapadia

August 02, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

News Industry News

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

July 11, 2017

News Daily News

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Caitlin E. Cox

June 21, 2017

Presentation TVT 2017

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Presenter: Axel Linke, Jeffrey J. Popma, Susheel Kodali

June 15, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

A Description of the U.S. REFLECT Randomized Clinical Trial

Presenter: Jeffrey W. Moses

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Presentation TVT 2017

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Presenter: Jochen Wöhrle

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Axel Linke

June 15, 2017

Presentation TVT 2017

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem

June 15, 2017

News Daily News

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Shelley Wood

June 05, 2017

Advertisement

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Cerebral Embolic Protection: Point–Counter Point

EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

Cerebral Embolic Protection: Not Enough Evidence to Support Routine Clinical Use

How a CHIP Operator Manages Saphenous Vein Graft (SVG) Disease

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

Role of Embolic Protection during TAVR

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

A Description of the U.S. REFLECT Randomized Clinical Trial

Device Design Features and Findings From EU Clinical Trials

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content